Fermi Inc. Prices Upsized Offering of $375 Million of Convertible Senior Notes - Dilution Offset Until $14.64 per Share

Fermi Inc. upsized its 5.00% convertible senior notes offering to $375 million ($431.25 million if the $56.25 million option is fully exercised), with net proceeds of about $362.25 million ($416.81 million including the option). The initial conversion premium is 30% (conversion price ~$9.52 vs. $7.32 share price), while capped call structures set an effective conversion price at $14.64, targeting no dilution until that level. Notes will pay 5.00% annual interest and mature July 15, 2031, with sales/close expected July 14, 2026; proceeds will largely fund capped call transactions (~$30.0 million, or ~$34.5 million with the option) plus general corporate purposes.

Analysis

This is less a dilution event than a balance-sheet bridge: the company is buying time, not necessarily creating value. The capped call softens the near-term equity hit, but the financing still telegraphs that the market is underwriting a capital-intensive story with external capital rather than internal cash generation. In the next few sessions, the main pressure is likely mechanical from dealer hedging and convertible arb positioning, which can distort price action more than the fundamental impact.

The more interesting second-order effect is that FRMI becomes a volatility instrument: below the strike area, the notes behave like expensive debt plus an equity overhang; above it, the structure can turn into a squeeze if hedges have to be unwound and the stock starts to self-fund the convert optionality. That makes the trade horizon asymmetric: days for the hedge-flow impact, 1-3 months for whether management can show that this capital meaningfully extends runway, and 6-18 months for whether the business reaches a scale where future raises are no longer punitive.

Contrarian view: the market may be overreacting to the headline dilution while underreacting to the signal embedded in the need for a convert at this stage. The key falsifier is a follow-up disclosure showing materially better cash runway, lower burn, or a credible operating milestone; absent that, every rally into this financing should be treated as a chance for the street to distribute stock into strength rather than a clean re-rating catalyst.

Key Decisions for Investors

• Tactically short FRMI on post-closing strength once initial hedge flow settles; use a tight stop on a sustained move through $9.52, because above the conversion price the deal starts to behave more like a squeeze than a dilution overhang.
• If options are liquid, prefer a defined-risk bearish structure in the next 1-2 months: buy put spreads or sell call spreads rather than outright short stock, since the capped call can blunt downside in the near term.
• For existing holders, reduce exposure into any financing-driven bounce unless management simultaneously discloses improved cash runway or a near-term commercial milestone; the burden of proof is on fundamentals, not the structure.
• Set an alert for a clean break above $14.64 on meaningful volume; that level is where the capped call stops fully insulating dilution and the stock could re-rate on forced hedge unwind.